Stockscreener 앱 받기
46.23
0.00%
0.00
시간 외 거래:
46.22
-0.010
-0.02%
전일 마감가:
$46.23
열려 있는:
$46.21
하루 거래량:
3.79M
Relative Volume:
0.87
시가총액:
$3.46B
수익:
-
순이익/손실:
$-275.16M
주가수익비율:
-11.88
EPS:
-3.89
순현금흐름:
$-221.15M
1주 성능:
+0.11%
1개월 성능:
+18.27%
6개월 성능:
+46.34%
1년 성능:
+2.48%
1일 변동 폭
$46.20
$46.27
1주일 범위
$46.05
$46.30
52주 변동 폭
$28.21
$62.00
Springworks Therapeutics Inc Stock (SWTX) Company Profile
명칭
Springworks Therapeutics Inc
전화
203-883-9490
주소
100 WASHINGTON BOULEVARD, STAMFORD, CT
SWTX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SWTX
Springworks Therapeutics Inc
|
46.23 | 3.46B | 0 | -275.16M | -221.15M | -3.89 |
|
VRTX
Vertex Pharmaceuticals Inc
|
500.19 | 127.64B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
603.58 | 65.95B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
656.65 | 37.92B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
273.55 | 32.98B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ONC
Beigene Ltd Adr
|
254.16 | 26.92B | 3.81B | -644.79M | -669.77M | -6.24 |
Springworks Therapeutics Inc Stock (SWTX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-11-20 | 개시 | Evercore ISI | Outperform |
| 2024-02-05 | 개시 | Guggenheim | Buy |
| 2022-12-01 | 개시 | BofA Securities | Buy |
| 2021-01-19 | 재확인 | H.C. Wainwright | Buy |
| 2020-10-29 | 재확인 | H.C. Wainwright | Buy |
| 2020-05-05 | 개시 | Barclays | Overweight |
| 2020-03-19 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2020-03-04 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2020-01-21 | 재확인 | H.C. Wainwright | Buy |
| 2019-12-04 | 개시 | H.C. Wainwright | Buy |
| 2019-10-08 | 개시 | Cowen | Outperform |
| 2019-10-08 | 개시 | Goldman | Buy |
| 2019-10-08 | 개시 | JP Morgan | Overweight |
| 2019-10-08 | 개시 | Wedbush | Outperform |
모두보기
Springworks Therapeutics Inc 주식(SWTX)의 최신 뉴스
ArrowMark Colorado Holdings LLC Acquires 7,072 Shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
Soros Fund Management LLC Purchases 41,149 Shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
SpringWorks Therapeutics (NASDAQ:SWTX) Rating Lowered to Hold at Evercore ISI - MarketBeat
Merck KGaA (MKGAF) to Acquire SpringWorks Therapeutics for $3.9 Billion - GuruFocus
(SWTX) Trading Report - news.stocktradersdaily.com
SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Shares Sold by Ally Bridge Group NY LLC - MarketBeat
Boxer Capital Management LLC Acquires New Holdings in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
SpringWorks Therapeutics' (SWTX) "Hold" Rating Reiterated at TD Cowen - MarketBeat
Merck KGaA’s $3.9 Billion Springworks Deal to Boost US Presence - MSN
SpringWorks Therapeutics (NASDAQ:SWTX) Shares Gap UpHere's Why - MarketBeat
Brokerages Set SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Price Target at $63.17 - MarketBeat
Wedbush Reiterates "Neutral" Rating for SpringWorks Therapeutics (NASDAQ:SWTX) - MarketBeat
SpringWorks Therapeutics (NASDAQ:SWTX) Receives "Equal Weight" Rating from Barclays - MarketBeat
Price T Rowe Associates Inc. MD Sells 241,632 Shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Shares Sold by Nebula Research & Development LLC - MarketBeat
SpringWorks Therapeutics’ (SWTX) “Neutral” Rating Reiterated at HC Wainwright - Defense World
Top Mid Cap Stocks Worth WatchingApril 28th - MarketBeat
Voya Investment Management LLC Acquires 67,559 Shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
Taxation With Representation: Goodwin, Haynes Boone - Law360
SpringWorks Therapeutics' (SWTX) "Neutral" Rating Reiterated at HC Wainwright - MarketBeat
Lord Abbett & CO. LLC Trims Stock Holdings in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RGLS, KRON, SWTX on Behalf of Shareholders - marketscreener.com
Biotech Alert: Searches spiking for these stocks today - Yahoo Finance
TD Cowen Reaffirms Hold Rating for SpringWorks Therapeutics (NASDAQ:SWTX) - Defense World
SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Receives $63.17 Consensus Price Target from Brokerages - Defense World
SpringWorks Therapeutics (NASDAQ:SWTX) Cut to “Hold” at Evercore ISI - Defense World
SpringWorks Therapeutics (SWTX) Downgraded Amid Acquisition Deal - GuruFocus
13,556 Shares in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Purchased by Syon Capital LLC - MarketBeat
SPRINGWORKS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of SpringWorks Therapeutics, Inc.SWTX - Business Wire
HC Wainwright Downgrades Springworks Therapeutics to Neutral From Buy, Adjusts Price Target to $47 From $74 - marketscreener.com
SpringWorks Therapeutics (SWTX) Downgraded by H.C. Wainwright Du - GuruFocus
SpringWorks Therapeutics (NASDAQ:SWTX) Sees Unusually-High Trading VolumeStill a Buy? - MarketBeat
Merck KGaA Nears Deal to Buy SpringWorks Therapeutics - MSN
Merck KGaA to Buy US Biotech Springworks for $3.9 Billion - MSN
Germany's Merck KGaA in $3.9 billion deal to buy US biotech firm SpringWorks - Reuters
Merck’s $3.9 Billion Acquisition of SpringWorks Therapeutics - Global Legal Chronicle
SpringWorks: Acquired By Merck KGaA Based On Rare Tumor Targeting Drugs Like OGSIVEO - Seeking Alpha
Merck KGaA to Acquire SpringWorks for $3.9B, Expanding Rare Cancer Footprint - Genetic Engineering and Biotechnology News
Wall Street Analysts Believe SpringWorks Therapeutics (SWTX) Could Rally 42.29%: Here's is How to Trade - Yahoo Finance
Guggenheim Downgrades Springworks Therapeutics to Neutral From Buy, Adjusts Price Target to $47 From $77 - marketscreener.com
TD Cowen Downgrades Springworks Therapeutics to Hold From Buy, Adjusts Price Target to $47 From $66 - marketscreener.com
Germany’s Merck KGaA in $3.9 billion deal to buy US biotech firm SpringWorks - 1330 & 101.5 WHBL
SpringWorks Therapeutics Retail Chatter Spikes As Germany’s Merck Confirms Late-Stage Talks For $3.5B Buyout - MSN
BofA Keeps Merck at Buy Amid SpringWorks Acquisition - marketscreener.com
SpringWorks Therapeutics (SWTX) to Release Earnings on Thursday - MarketBeat
Merck to acquire US-based biotech firm SpringWorks for $3.9bn - World Pharmaceutical Frontiers
German pharma giant Merck to acquire US biotech firm SpringWorks in $3.9B deal - Türkiye Today
SHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of SpringWorks Therapeutics, Inc.SWTX - The Malaysian Reserve
Merck KGaA to Acquire SpringWorks Therapeutics (SWTX) for $3.9 B - GuruFocus
SpringWorks Therapeutics (SWTX) Downgraded Amid Acquisition Deal | SWTX Stock News - GuruFocus
Merck To Buy SpringWorks Therapeutics For $3.9 Billion, Marking Major Expansion - MSN
Springworks Therapeutics Inc (SWTX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.39%
3.66%
자본화:
|
볼륨(24시간):